Staff Publications Received in March 2014

Staff Publications Received in March 2014

1.       Bleicher RJ, Topham NS, Morrow M. Reply to letter: “Anaplastic large cell lymphomas and breast implants”. Annals of surgery, 259(1):e5, 2014. [Letter]. Read the article.

2.       Budina-Kolomets A, Balaburski GM, Bondar A, Beeharry N, Yen T, Murphy ME. Comparison of the activity of three different HSP70 inhibitors on apoptosis, cell cycle arrest, autophagy inhibition, and HSP90 inhibition. Cancer Biology & Therapy, 15(2):194-9, 2014. Read the article.

3.       Doss M. Conclusion of Increased Risk of Cataracts Associated With CT Studies of the Head May Not Be Justified. AJR American journal of roentgenology, 202(4):W413, 2014. [Letter]. Read the article.

4.       Doss M. No Increased Risk of Cancer From CT. AJR American journal of roentgenology, 202(4):W410, 2014. [Letter]. Read the article.

5.       Doss M. Radiation doses from radiological imaging do not increase the risk of cancer. The British journal of radiology, 87(1036):20140085, 2014. [Letter]. Read the article.

6.       Doss M. Adoption of linear no-threshold model violated basic scientific principles and was harmful. Archives of Toxicology, 88(3):849-52, 2014. [Letter]. Read the article.

7.       Fang CY, Egleston BL, Manzur AM, Townsend RR, Stanczyk FZ, Spiegel D, Dorgan JF. Psychological reactivity to laboratory stress is associated with hormonal responses in postmenopausal women. The Journal of international medical research, 42(2):444-56, 2014. Read the article.

8.       Gao W, Ma GX, Tan Y, Fang C, Weaver J, Jin M, Lai P, Godwin AK. Culturally Appropriate Education Intervention on Biospecimen Research Participation among Chinese Americans. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 23(3):383-91, 2014. PMC3955025. Read the article.

9.       Giersch K, Helbig M, Volz T, Allweiss L, Mancke LV, Lohse AW, Polywka S, Pollok JM, Petersen J, Taylor J, Dandri M, Lutgehetmann M. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. Journal of Hepatology, 60(3):538-44, 2014. Read the article.

10.     Ginzburg S, Kutikov A. Does every second really count when it comes to renal ischemia during nephron sparing surgery? Canadian Journal of Urology, 21(1):7134, 2014. [Editorial]. Read the article.

11.     Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DYT, Greenberg R, Smaldone M, Kutikov A. Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy. Journal of Urology, 191(2):296-300, 2014. Read the article.

12.     Goldsack JC, Reilly C, Bush C, McElligott S, Bristol MN, Motanya UN, Field R, Vozniak JM, Wong YN, Schwartz JS, Domchek S. Impact of shortages of injectable oncology drugs on patient care. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 71(7):571-8, 2014. Read the article.

13.     Goldstein LJ, Miller BJ, Nicotera N, Pendleton D. Reducing the time from initial call to first appointment: the impact of patient access redesign and a nurse navigation program. Journal of the National Comprehensive Cancer Network : JNCCN, 12 Suppl 1:S16-8, 2014. Read the article.

14.     Gupta S, Melnyk SB, Kruger WD. Cystathionine beta-synthase-deficient mice thrive on a low-methionine diet. Faseb Journal, 28(2):781-90, 2014. Read the article.

15.     Haery L, Lugo-Pico JG, Henry RA, Andrews AJ, Gilmore TD. Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth. Molecular Cancer, 13:Article number 29, 2014. Read the article.

16.     Handorf EA, Smaldone MC. Editorial comment. Urology, 83(1):132-3; discussion 3, 2014. [Comment]. Read the article.

17.     Hardy RR, Roederer M. Leonard Herzenberg (1931-2013): The Life of FACS Obituary. Immunity, 39(6):989-91, 2013. [Obituary]. Read the article.

18.     Johnson ME, Ruth K, Buyyounouski MK, Horwitz EM. Seminal Vesicle Target Delineation for Intermediate-Risk Prostate Cancer IMRT. Practical radiation oncology, 3(2 Suppl 1):S31-2, 2013. Read the article.

19.     Johnson ME, Turaka A, Zhu F, Galloway T, Farma J, Perlis C. Absolute lymphocyte count: a novel prognostic factor for merkel cell carcinoma. Practical radiation oncology, 3(2 Suppl 1):S10-1, 2013. Read the article.

20.     Jones DZ, Ragin C, Kidd NC, Flores-Obando RE, Jackson M, McFarlane-Anderson N, Tulloch-Reid M, Kimbro KS, Kidd LR. The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study. Hereditary Cancer in Clinical Practice, 11: Article 19, 2013. Read the article.

21.     Kocher NJ, Tomaszewski JJ, Parsons RB, Cronson BR, Altman H, Kutikov A. Splenogonadal fusion: a rare etiology of solid testicular mass. Urology, 83(1):e1-2, 2014. [Editorial]. Read the article.

22.     Law MJ, Mallory MJ, Dunbrack RL, Strich R. Acetylation of the Transcriptional Repressor Ume6p Allows Efficient Promoter Release and Timely Induction of the Meiotic Transient Transcription Program in Yeast. Molecular and Cellular Biology, 34(4):631-42, 2014. Read the article.

23.     Liang L, Zhu J, Zaorsky NG, Deng Y, Wu X, Liu Y, Liu F, Cai G, Gu W, Shen L, Zhang Z. MicroRNA-223 Enhances Radiation Sensitivity of U87MG Cells In Vitro and In Vivo by Targeting Ataxia Telangiectasia Mutated. International journal of radiation oncology, biology, physics, 88(4):955-60, 2014. Read the article.

24.     Lloyd JC, Madden-Fuentes RJ, Nelson CP, Kokorowski PJ, Wiener JS, Ross SS, Kutikov A, Routh JC. Response to “Reputation rankings for pediatric urology moderately”. Journal of Pediatric Urology, 10(1):201-2, 2014. [Letter]. Read the article.

25.     Matro JM, Goldstein LJ. How Do I Follow Patients With Early Breast Cancer After Completing Adjuvant Therapy. Current Treatment Options in Oncology, 15(1):63-78, 2014. Read the article.

26.     Meng ZJ, Ma ZY, Zhang EJ, Kosinska AD, Liu J, Zhang XY, Zhou TL, Wu J, Dahmen U, Dirsch O, Yang DL, Roggendorf M, Lu MJ. Novel Woodchuck Hepatitis Virus (WHV) Transgene Mouse Models Show Sex-Dependent WHV Replicative Activity and Development of Spontaneous Immune Responses to WHV Proteins. Journal of Virology, 88(3):1573-81, 2014. Read the article.

27.     Minton O, Berger A, Barsevick A, Cramp F, Goedendorp M, Mitchell SA, Stone PC. Cancer-Related Fatigue and Its Impact on Functioning. Cancer, 119:2124-30, 2013. Read the article.

28.     Pagoto S, Hillhouse J, Heckman CJ, Coups EJ, Stapleton J, Buller D, Turrisi R, Robinson J, Geller AC. Society of Behavioral Medicine (SBM) position statement: ban indoor tanning for minors. Translational behavioral medicine, 4(1):124-6, 2014. PMC3958596. Read the article.

29.     Price RA, Jr., Koren S, Veltchev I, Hossain M, Lin MH, Galloway T, Flanagan P, Haber J, Ma CM. Planning target volume-to-skin proximity for head-and-neck intensity modulated radiation therapy treatment planning. Practical radiation oncology, 4(1):e21-9, 2014. Read the article.

30.     Quino LAV, Chen XM, Fitzpatrick M, Shi CY, Stathakis S, Gutierrez A, Esquivel C, Mavroidis P, Alkhatib H, Papanikolaou N. Patient Specific Pre-treatment QA Verification using an EPID Approach. Technology in Cancer Research & Treatment, 13(1):1-10, 2014. Read the article.

31.     Reyngold M, Niland J, Ter Veer A, Milne D, Bekaii-Saab T, Cohen SJ, Lai L, Schrag D, Skibber JM, Small W, Jr., Weiser M, Wilkinson N, Goodman KA. Neoadjuvant Radiotherapy Use in Locally Advanced Rectal Cancer at NCCN Member Institutions. Journal of the National Comprehensive Cancer Network : JNCCN, 12(2):235-43, 2014. Read the article.

32.     Saha S, Chernoff J. Analysis of PTP1B sumoylation. Methods, 65(2):201-6, 2014. Read the article.

33.     Shaw AT, Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T, Riely GJ, Solomon BJ, Wolf J, Thomas M, Schuler M, Liu G, Santoro A, Lau YY, Goldwasser M, Boral AL, Engelman JA. Ceritinib in ALK-rearranged non-small-cell lung cancer. The New England journal of medicine, 370(13):1189-97, 2014. Read the article.

34.     Shlomi T, Fan J, Tang BQ, Kruger WD, Rabinowitz JD. Quantitation of Cellular Metabolic Fluxes of Methionine. Analytical Chemistry, 86(3):1583-91, 2014. Read the article.

35.     Stiff PJ, Unger JM, Fisher RI. The Role of Myeloablation for Lymphoma Reply. New England Journal of Medicine, 370(6):575-6, 2014. [Letter]. Read the article.

36.     Su S, Scott WJ, Allen MS, Darling GE, Decker PA, McKenna RJ, Meyers BF. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial. The Journal of thoracic and cardiovascular surgery, 147(2):747-52: Discussion 52-3, 2014. Read the article.

37.     Taguchi T, Mezaki T, Iwase F, Sekida S, Kubota S, Fukami H, Okuda K, Shinbo T, Oshima S, Iiguni Y, Testa JR, Tominaga A. Molecular Cytogenetic Analysis of the Scleractinian Coral Acropora solitaryensis Veron & Wallace 1984. Zoological Science, 31(2):89-94, 2014. Read the article.

38.     Taioli E, Joseph GR, Robertson L, Eckstein S, Ragin C. Knowledge and Prevention Practices Before Breast Cancer Diagnosis in a Cross-Sectional Study Among Survivors: Impact on Patients’ Involvement in the Decision Making Process. Journal of Cancer Education, 29(1):44-9, 2014. Read the article.

39.     Tait LM, Meyer JE, McSpadden E, Cheng JD, Baciewicz FA, Meropol NJ, Cohen SJ, Wozniak AJ, Choi M, Konski AA. Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma. Practical radiation oncology, 3(4):e149-55, 2013. Read the article.

40.     Taylor JM. Host RNA circles and the origin of hepatitis delta virus. World journal of gastroenterology : WJG, 20(11):2971-8, 2014. PMC3961984. Read the article.

41.     Tokar JL, Walia R. Diagnostic evaluation of solid pancreatic masses. Current gastroenterology reports, 15(10):347, 2013. Read the article.

42.     Tomaszewski JJ, Uzzo RG, Kutikov A, Hrebinko K, Mehrazin R, Corcoran A, Ginzburg S, Viterbo R, Chen DY, Greenberg RE, Smaldone MC. Assessing the Burden of Complications After Surgery for Clinically Localized Kidney Cancer by Age and Comorbidity Status. Urology, 83(4):843-50, 2014. Read the article.

43.     Twelves C, Chmielowska E, Havel L, Popat S, Swieboda-Sadlej A, Sawrycki P, Bycott P, Ingrosso A, Kim S, Williams JA, Chen C, Olszanski AJ, de Besi P, Schiller JH. Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer. Annals of Oncology, 25(1):132-8, 2014. Read the article.

44.     Wangari-Talbot J, Hopper-Borge E. Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma. Journal of cancer research updates, 2(4):265-82, 2013. PMC3952141. Read the article.

Posted in Uncategorized | Leave a comment

Staff Publications Received in February 2014

Staff Publications Received in February 2014

1.         Atay S, Banskota S, Crow J, Sethi G, Rink L, Godwin AK. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proceedings of the National Academy of Sciences of the United States of America, 111(2):711-6, 2014. Read the article.

2.         Behrend SW. Update on … tobacco control. [Column] Oncology nursing forum, 41(2):215-6, 2014. Read the article.

3.         Bepler G, Williams C, Schell MJ, Chen W, Zheng Z, Simon G, Gadgeel S, Zhao XH, Schreiber F, Brahmer J, Chiappori A, Tanvetyanon T, Pinder-Schenck M, Gray J, Haura E, Antonia S, Fischer JR. Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 31(19):2404-12, 2013. Read the article.

4.         Bleicher RJ. Breast magnetic resonance imaging as it is, in contrast to how we wish it to be. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(5):370-2, 2014. Read the article.

5.         Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J, Majewski T, Zhang S, Pretzsch S, Baggerly K, Siefker-Radtke A, Czerniak B, Dinney CP, McConkey DJ. Identification of distinct Basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer cell, 25(2):152-65, 2014. Read the article.

6.         Chou W-yS, Prestin A, Lyons C, Wen K-y. Web 2.0 for health promotion: Reviewing the current evidence. American Journal of Public Health, 103 (1):e9-e18, 2013. Read the article.

7.         Coccia PF, Pappo AS, Altman J, Bhatia S, Borinstein SC, Flynn J, Frazier AL, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Reed D, Spraker HL, Thomas DA, von Mehren M, Wechsler DS, Whelan KF, Zebrack B, Shead DA, Sundar H. Adolescent and Young Adult Oncology, Version 2.2014. Journal of the National Comprehensive Cancer Network, 12(1):21-32, 2014. Read the article.

8.         Coffey F, Lee SY, Buus TB, Lauritsen JP, Wong GW, Joachims ML, Thompson LF, Zuniga-Pflucker JC, Kappes DJ, Wiest DL. The TCR ligand-inducible expression of CD73 marks gammadelta lineage commitment and a metastable intermediate in effector specification. The Journal of experimental medicine, 211(2):329-43, 2014. PMC3920555. Read the article.

9.         DeMatteo RP, Ballman KV, Antonescu CR, Corless C, Kolesnikova V, von Mehren M, McCarter MD, Norton J, Maki RG, Pisters PWT, Demetri GD, Brennan MF, Owzar K, Acosog. Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk, Primary Gastrointestinal Stromal Tumor ACOSOG Z9000 (Alliance) Intergroup Phase 2 Trial. Annals of Surgery, 258(3):422-9, 2013. Read the article.

10.        Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O’Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D. Survivorship: Introduction and Definition. Journal of the National Comprehensive Cancer Network, 12(1):34-45, 2014. Read the article.

11.        Dong B, Duan X, Chow HY, Chen L, Lu H, Wu W, Hauck B, Wright F, Kapranov P, Xiao W. Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors. PloS one, 9(2):e86453, 2014. PMC3911921. Read the article.

12.        Doss M. Adoption of linear no-threshold model violated basic scientific principles and was harmful : Letter from Mohan Doss regarding Edward Calabrese’s paper “How the US National Academy of Sciences misled the world community on cancer risk assessment: new findings challenge historical foundations of the linear dose response” (Arch Toxicol (2013) 87:2063-2081) and the Letter from Ralph J Cicerone (Arch Toxicol (2014) 88:171-172) [Letter]. Archives of toxicology, 88(3):849-52, 2014. Read the article.

13.        Duncan KE, Cook PM, Gavett SH, Dailey LA, Mahoney RK, Ghio AJ, Roggli VL, Devlin RB. In vitro determinants of asbestos fiber toxicity: effect on the relative toxicity of Libby amphibole in primary human airway epithelial cells. Particle and Fibre Toxicology, 11:article 2, 2014. Read the article.

14.        Eldib A, Jin L, Li J, Charlie Ma CM. Investigation of the clinical potential of scattering foil free electron beams. Physics in medicine and biology, 59(4):819-36, 2014. Read the article.

15.        Evans AA, London WT, Gish RG, Cohen C, Block TM. Chronic HBV infection outside treatment guidelines: is treatment needed? Antiviral Therapy, 18(2):229-35, 2013. Read the article.

16.        Falk RT, Brinton LA, Dorgan JF, Fuhrman BJ, Veenstra TD, Xu X, Gierach GL. Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Research, 15(2):R34, 2013. Read the article.

17.        Fazelinia H, Xu M, Cheng H, Roder H. Ultrafast Hydrogen Exchange Reveals Specific Structural Events during the Initial Stages of Folding of Cytochrome c. Journal of the American Chemical Society, 136(2):733-40, 2014. Read the article.

18.        Ferris JS, Daly MB, Buys SS, Genkinger JM, Liao Y, Terry MB. Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry. British journal of cancer, 110(4):1074-80, 2014. PMC3929882. Read the article.

19.        Gabriel KP, Klifa C, Perez A, Kriska AM, High RR, Snetselaar L, Dorgan JF. Adolescent and Young Adult Exposure to Physical Activity and Breast Density. Medicine and Science in Sports and Exercise, 45(8):1515-23, 2013. Read the article.

20.        Handorf EA, Bekelman JE, Heitjan DF, Mitra N. EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT. Annals of Applied Statistics, 7(4):2062-80, 2013. Read the article.

21.        Hodak E, Lessin S, Friedland R, Freud T, David M, Pavlovsky L, Shapiro J, Cohen AD. New Insights into Associated Co-morbidities in Patients with Cutaneous T-cell Lymphoma (Mycosis Fungoides). Acta Dermato-Venereologica, 93(4):451-5, 2013. Read the article.

22.        Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, deShazo M, Dotan E, Edil BH, Extermann M, Ganti AKP, Holmes HM, Jagsi R, Karlekar MB, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O’Connor T, Rugo HS, Rupper RW, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Weir AB, Bergman MA, Sundar H. Senior Adult Oncology, Version 2.2014. Journal of the National Comprehensive Cancer Network, 12(1):82-126, 2014. Read the article.

23.        Janne PA, Cohen RB, Laird AD, Mace S, Engelman JA, Ruiz-Soto R, Rockich K, Xu J, Shapiro GI, Martinez P, Felip E. Phase I Safety and Pharmacokinetic Study of the PI3K/mTOR Inhibitor SAR245409 (XL765) in Combination with Erlotinib in Patients with Advanced Solid Tumors. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 9(3):316-23, 2014. Read the article.

24.        Kaveh R, Li YS, Ranjbar S, Tehrani R, Brueck CL, Van Aken B. Changes in Arabidopsis thaliana Gene Expression in Response to Silver Nanoparticles and Silver Ions. Environmental Science & Technology, 47(18):10637-44, 2013. Read the article.

25.        Lal S, Burkhart RA, Beeharry N, Bhattacharjee V, Londin ER, Cozzitorto JA, Romeo C, Jimbo M, Norris ZA, Yeo CJ, Sawicki JA, Winter JM, Rigoutsos I, Yen TJ, Brody JR. HuR Posttranscriptionally Regulates WEE1: Implications for the DNA Damage Response in Pancreatic Cancer Cells. Cancer research, 74(4):1128-40, 2014. Read the article.

26.        Licciulli S, Maksimoska J, Zhou C, Troutman S, Kota S, Liu Q, Duron S, Campbell D, Chernoff J, Field J, Marmorstein R, Kissil JL. FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas. Journal of Biological Chemistry, 288(40):29105-14, 2013. Read the article.

27.        Little JL, Serzhanova V, Izumchenko E, Egleston BL, Parise E, Klein-Szanto AJ, Loudon G, Shubina M, Seo S, Kurokawa M, Ochs MF, Golemis EA. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice. Oncogene, 33(4):411-20, 2014. Read the article.

28.        Montalvo GL, Gai F, Roder H, DeGrado WF. Slow Folding-Unfolding Kinetics of an Octameric beta-Peptide Bundle. Acs Chemical Biology, 9(1):276-81, 2014. Read the article.

29.        Moy B, Bradbury AR, Helft PR, Egleston BL, Sheikh-Salah M, Peppercorn J. Correlation Between Financial Relationships With Commercial Interests and Research Prominence at an Oncology Meeting. Journal of Clinical Oncology, 31(21):2678-84, 2013. Read the article.

30.        Tulina NM, Chen WF, Chen JH, Sowcik M, Sehgal A. Day-night cycles and the sleep-promoting factor, Sleepless, affect stem cell activity in the Drosophila testis. Proceedings of the National Academy of Sciences of the United States of America, 111(8):3026-31, 2014. Read the article.

31.        Wang X, Wang Y, Zhou Y, Hendron E, Mancarella S, Andrake MD, Rothberg BS, Soboloff J, Gill DL. Distinct Orai-coupling domains in STIM1 and STIM2 define the Orai-activating site. Nature communications, 5:3183, 2014. Read the article.

32.        Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. Future oncology (London, England), 10(3):457-74, 2014. Read the article.

33.        Zhang WZ, Grivennikov SI. Top Notch cancer stem cells by paracrine NF-kappa B signaling in breast cancer. Breast Cancer Research, 15(5):316, 2013. Read the article.

Posted in Uncategorized | Leave a comment

Staff Publications Received in January 2014

Staff Publications Received in January 2014

1.            Ahmed AA, Egleston B, Holliday E, Eastwick G, Takita C, Jagsi R. Gender Trends in Radiation Oncology in the United States: A 30-Year Analysis. International Journal of Radiation Oncology Biology Physics, 88(1):33-8, 2014. Read the article.

2.            Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Jasperson K, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Dwyer M, Freedman-Cass D. Colorectal Cancer Screening Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 11(12):1538-75, 2013.  Read the article.

3.            Chen C, Ha BH, Thevenin AF, Lou HJ, Zhang R, Yip KY, Peterson JR, Gerstein M, Kim PM, Filippakopoulos P, Knapp S, Boggon TJ, Turk BE. Identification of a Major Determinant for Serine-Threonine Kinase Phosphoacceptor Specificity. Molecular Cell, 53(1):140-7, 2014.  Read the article.

4.            Daly JM. A marriage of databases produces knowledge offspring. [comment] Annals of surgery, 258(6):845-6, 2013.  Read the article.

5.            Dames DN, Blackman E, Butler R, Taioli E, Eckstein S, Devarajan K, Griffith-Bowe A, Gomez P, Ragin C. High-Risk Cervical Human Papillomavirus Infections among Human Immunodeficiency Virus-Positive Women in the Bahamas. PloS one, 9(1):e85429, 2014. PMC3900425.  Read the article.

6.            Desilets DJ, Banerjee S, Barth BA, Bhat YM, Gottlieb KT, Maple JT, Pfau PR, Pleskow DK, Siddiqui UD, Tokar JL, Wang A, Rodriguez SA. New devices and techniques for management of pancreatic fluid collections. Gastrointestinal endoscopy, 77(6):835-8, 2013.  Read the article.

7.            Gabitova L, Gorin A, Astsaturov I. Molecular Pathways: Sterols and Receptor Signaling in Cancer. Clinical Cancer Research, 20(1):28-34, 2014.  Read the article.

8.            Ginzburg S, Golovine KV, Makhov PB, Uzzo RG, Kutikov A, Kolenko VM. Piperlongumine Inhibits NF-kappa B Activity and Attenuates Aggressive Growth Characteristics of Prostate Cancer Cells. Prostate, 74(2):177-86, 2014.  Read the article.

9.            Han LC, Kim SP, Gross CP, Ross JS, Van Houten HK, Smaldone MC, Krambeck AE, Shah ND. Association of physician specialty and medical therapy for benign prostatic hyperplasia. Medical care, 52(2):128-36, 2014.  Read the article.

10.          Harmon CS, DePrimo SE, Figlin RA, Hudes GR, Hutson TE, Michaelson MD, Negrier S, Kim ST, Huang X, Williams JA, Eisen T, Motzer RJ. Circulating proteins as potential biomarkers of sunitinib and interferon-alpha efficacy in treatment-naive patients with metastatic renal cell carcinoma. Cancer Chemotherapy and Pharmacology, 73(1):151-61, 2014.  Read the article.

11.          Heckman KL, DeCoteau W, Estevez A, Reed KJ, Costanzo W, Sanford D, Leiter JC, Clauss J, Knapp K, Gomez C, Mullen P, Rathbun E, Prime K, Marini J, Patchefsky J, Patchefsky AS, Hailstone RK, Erlichman JS. Custom Cerium Oxide Nanoparticles Protect against a Free Radical Mediated Autoimmune Degenerative Disease in the Brain. Acs Nano, 7(12):10582-96, 2013.  Read the article.

12.          Held-Warmkessel J, Schiech L. Non-small cell lung cancer: Recent advances. Nursing, 44(2):32-42, 2014.  Read the article.

13.          Isayeva T, Xu J, Dai Q, Whitley AC, Bonner J, Nabell L, Spencer S, Carroll W, Jones G, Ragin C, Brandwein-Gensler M. African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis. Human pathology, 45(2):310-9, 2014.  Read the article.

14.          Jin L, Eldib A, Li J, Emam I, Fan J, Wang L, Ma CM. Measurement and Monte Carlo simulation for energy- and intensity-modulated electron radiotherapy delivered by a computer-controlled electron multileaf collimator. Journal of applied clinical medical physics / American College of Medical Physics, 15(1):4506, 2014.  Read the article.

15.          Kerlin MP, Tokar JL. Acute gastrointestinal bleeding. [comment].Annals of internal medicine, 159(11):793-4, 2013.  Read the article.

16.          Lillington L, Scaramuzzo L, Friese C, Sein E, Harrison K, LeFebvre KB, Fessele K. Improving Practice One Patient, One Nurse, One Day at a Time: Design and Evaluation of a Quality Education Workshop for Oncology Nurses. Clinical Journal of Oncology Nursing, 17(6):584-7, 2013.  Read the article.

17.          Loveland-Jones CE, Ruth K, Sigurdson ER, Egleston BL, Boraas M, Bleicher RJ. Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care? Breast cancer research and treatment, 143(3):571-7, 2014.  Read the article.

18.          Manne S, Myers S, Ozga M, Kissane D, Kashy D, Rubin S, Heckman C, Rosenblum N. Holding back sharing concerns, dispositional emotional expressivity, perceived unsupportive responses and distress among women newly diagnosed with gynecological cancers. General Hospital Psychiatry, 36(1):81-7, 2014.  Read the article.

19.          Mentlik- James A, Cohen AD, Campbell KS. Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells. Frontiers in immunology, 4:481, 2013. PMC3870292.  Read the article.

20.          Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kawachi MH, Kuettel M, Lee RJ, MacVicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Richey S, Roach M, Rohren E, Rosenfeld S, Small EJ, Srinivas S, Stein C, Strope SA, Tward J, Walsh PC, Shead DA, Ho M. Prostate Cancer, Version 1.2014 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network, 11(12):1471-9, 2013.  Read the article.

21.          Moore R, Cai KQ, Tao W, Smith ER, Xu XX. Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues. BMC Dev Biol, 13:39, 2013.  Read the article.

22.          Natsuizaka M, Kinugasa H, Kagawa S, Whelan KA, Naganuma S, Subramanian H, Chang S, Nakagawa KJ, Rustgi NL, Kita Y, Natsugoe S, Basu D, Gimotty PA, Klein-Szanto AJ, Diehl JA, Nakagawa H. IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment. American journal of cancer research, 4(1):29-41, 2014. PMC3902230.  Read the article.

23.          Naumann RW, Coleman RL, Burger RA, Sausville EA, Kutarska E, Ghamande SA, Gabrail NY, DePasquale SE, Nowara E, Gilbert L, Gersh RH, Teneriello MG, Harb WA, Konstantinopoulos PA, Penson RT, Symanowski JT, Lovejoy CD, Leaman CP, Morgenstern DE, Messmann RA. PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer. Journal of Clinical Oncology, 31(35):4400-+, 2013.  Read the article.

24.          Paltser G, Liu XJ, Yantha J, Winer S, Tsui H, Wu P, Maezawa Y, Cahill LS, Laliberte CL, Ramagopalan SV, DeLuca GC, Sadovnick AD, Astsaturov I, Ebers GC, Henkelman RM, Salter MW, Dosch HM. TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis. Molecular Medicine, 19:149-59, 2013.  Read the article.

25.          Patrick-Miller L, Egleston BL, Daly M, Stevens E, Fetzer D, Forman A, Bealin L, Rybak C, Peterson C, Corbman M, Bradbury AR. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results. Patient Education and Counseling, 93(3):413-9, 2013.  Read the article.

26.          Perini GF, Pro B. Brentuximab Vedotin in CD30+ Lymphomas. Biologics in therapy, 3:15-23, 2013. PMC3873074.  Read the article.

27.          Poleshko A, Mansfield KM, Burlingame CC, Andrake MD, Shah NR, Katz RA. The human protein PRR14 tethers heterochromatin to the nuclear lamina during interphase and mitotic exit. Cell reports, 5(2):292-301, 2013. PMC3867587.  Read the article.

28.          Ridge JA, Lawson J, Yom SS, Garg MK, McDonald MW, Quon H, Saba N, Salama JK, Smith RV, Worden F, Yeung AR, Beitler JJ. American College of Radiology Appropriateness Criteria (R) treatment of stage I T1 glottic cancer. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 36(1):3-8, 2014.  Read the article.

29.          Shen C, Chien CR, Geynisman DM, Smieliauskas F, Shih YC. A review of economic impact of targeted oral anticancer medications. Expert review of pharmacoeconomics & outcomes research, 14(1):45-69, 2014.  Read the article.

30.          Thomay AA, Nagorney DM, Cohen SJ, Sigurdson ER, Truty MJ, Burtness B, Hall MJ, Chun YS. Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer. Journal of Gastrointestinal Surgery, 18(1):69-73, 2014.  Read the article.

31.          Tseng M, Byrne C, Kurzer MS, Fang CY. Equol-Producing Status, Isoflavone Intake, and Breast Density in a Sample of U.S. Chinese Women. Cancer Epidemiology Biomarkers & Prevention, 22(11):1975-83, 2013.  Read the article.

32.          Van Cleave JH, Egleston BL, Ercolano E, McCorkle R. Symptom Distress in Older Adults Following Cancer Surgery. Cancer Nursing, 36(4):292-300, 2013.  Read the article.

33.          Wang MJ, Mehta A, Block TM, Marrero J, Di Bisceglie AM, Devarajan K. A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables. Bmc Medical Genomics, 6:S9, 2013.  Read the article.

34.          Wu TL, Li H, Faust SM, Chi E, Zhou SZ, Wright F, High KA, Ertl HCJ. CD8(+) T Cell Recognition of Epitopes Within the Capsid of Adeno-associated Virus 8-based Gene Transfer Vectors Depends on Vectors’ Genome. Molecular Therapy, 22(1):42-51, 2014.  Read the article.

Competitive Grant Awards, Notifications Received December 1, 2013 through December 31, 2014

PI: Egleston, Brian               Agency:   NIH, prime: Univ.   Title:  Pilot Study of Metabolomic Profiles and Epithelial Ovarian

R01 Supplement                     of MD, Baltimore               Cancer Risk

This administrative supplement is a subcontract to the University of Maryland, Baltimore.

PI: Egleston, Brian               Agency:   NIH, prime: Univ.   Title:  Adolescent Sex Hormones and Breast Density in Young

R03                                             of MD, Baltimore               Women

This project is a subcontract to University of Maryland, Baltimore.

PI: Sigal, Luis J                     Agency:   NIH, prime: GA       Title:  Immune Mechanisms that Control Ectromelia Virus Infection

U01                                             Regents Univ.                    Discretionary Funds

This award provides IMVC Discretionary Funds to be used for the purchase of a Leica CM3050 S Research Cryostat.

PI: Sykes, Stephen M          Agency:   WW SMITH              Title:  Control of Redox Homeostasis by JNK Signaling in Acute

Lyeloid Leukemis: Mechanisms and Therapeutic Implications

The major goals of this project are:  1) To define the molecular pathways utilized by the JNK/JUN axis to resist conventional

anti‑AML chemotherapies; and 2) To exploit the JNK/JUN signaling pathway to augment AML therapy.

PI: Testa, Joseph R             Agency:   NIH                            Title:  Pathogenesis of Malignant Mesothelioma by the Human

R01                                                                                            Polycomb Complex BAP1‑ASXL

The major goals of this project are: 1) To use a direct in vivo genetic approach to determine if heterozygous Bap1 (+/mut) mice are

predisposed to the development of various spontaneous tumors, including MM, and to accelerated asbestos‑induced MM; 2) To

use conditional knockout mice to determine if somatic loss of Bap1 alone in the mesothelium is capable of driving mesothelial

hyperplasia and/or frank MM, and if somatic Bap1 inactivation combined with loss of Nf2 and Cdkn2a results in more rapid

development and/or more aggressive disease, with potential prognostic and novel therapeutic implications; 3) To define the

spectrum of BAP1 and ASXL1/2 mutations in human MM specimens/cell lines and determine how these mutations affect binding

and function of BAP1 in complex with ASXL1/2 and other PR‑DUB complex proteins, and define the transcriptome and cellular

phenotype which are altered as a consequence of mutation of BAP1 and other PR‑DUB components in MM cells; and 4) To

determine the composition of the native PR‑DUB macromolecular protein complexes that contain wild‑type BAP1 and ASXL1/2 in

mesothelial cells and in BAP1‑ and/or ASXL1/2‑deficient MM cells to compare normal‑ and tumor‑specific subunit structure and the

role of these complexes in epigenetic dysregulation that occurs in MM.

PI: Yang, Zeng‑jie                 Agency:   NIH                            Title:  Leukotriene‑Induced Nestin Expression Promotes

R01                                                                                            Medulloblastoma Tumorigenesis

The major goals of this project are: 1) To determine the molecular basis for Nestin induction in Ptc‑deficient GNPs and tumor cells 2) To determine how Nestin regulates Shh signaling; and 3) To determine the role of Nestin in MB initiation and progression.

Posted in Uncategorized | Leave a comment

The New Web of Science

The Web of Knowledge – as it was formerly known – is now just Web of Science.  Along with the name change comes a sleek new interface created for an improved user experience.  New features include spell-check functionality, a Citation Network panel, and easier links to full-text.  The redesigned, simplified interface offers:

  • easier navigation with the browser’s back button
  • a universal header allowing for easier navigation to Journal Citation Reports & EndNote
  • a single search box
  • “My Tools” menu allowing access to personalization features
  • more language options
  • new Open Access refine option
  • new comprehensive “Citation Network” panel
  • new Metrics column
  • and more

Tutorials on using the new Web of Science features can be found through the following link: http://wokinfo.com/training_support/training/web-of-knowledge/

Posted in Uncategorized | Leave a comment

PubMed Central (PMC) Now Including Converted Multimedia Files in Downloads of Open Access Subset Articles

Previously, PubMed Central (PMC) converted only some multimedia files within the supplementary materials of articles in its collection into formats responsive to the web.  Now, these converted multimedia files are available through the open-access subset.  For more information on this new feature, click on the link below:

http://www.infodocket.com/2014/01/06/pubmed-central-pmc-now-including-converted-multimedia-files-in-downloads-of-open-access-subset-articles/

Posted in Uncategorized | Leave a comment

Access Online medical products move to a new web platform

AccessMedicine and AccessSurgery have moved to a new web platform, with an improved new user interface.  What does this mean for you?

• Greater Personalization
• Responsive Design for Mobile
• Federated Search (Coming in Q1)
• Remote Log-In with My Access account

Read more about the new platform changes here:  http://www.accessusercenter.com/?page_id=1929

Posted in Uncategorized | Leave a comment

Staff Publications Received in December 2013

Staff Publications Received in December, 2013

1.         Aggarwal C, Li L, Borghaei H, Mehra R, Somaiah N, Turaka A, Langer CJ, Simon GR. Multidisciplinary Therapy of Stage IIIA Non-Small-Cell Lung Cancer: Long-term Outcome of Chemoradiation With or Without Surgery. Cancer control : journal of the Moffitt Cancer Center, 21(1):57-62, 2014.  Read the article

2.         Anastassiadis T, Duong-Ly KC, Deacon SW, Lafontant A, Ma H, Devarajan K, Dunbrack RL, Jr., Wu J, Peterson JR. A highly selective dual insulin receptor (IR)/insulin-like growth factor 1 receptor (IGF-1R) inhibitor derived from an extracellular signal-regulated kinase (ERK) inhibitor. The Journal of biological chemistry, 288(39):28068-77, 2013. PMC3784719.  Read the article

3.         Azor Hui SK, Nazir N, Faseru B, Ellerbeck EF. Ongoing self-engagement in quit attempts and cessation outcomes among rural smokers who were unable to quit after 2 years of repeated interventions. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association, 29(1):106-12, 2013. PMC3539219.  Read the article

4.         Baldwin DA, Sarnowski CP, Reddy SA, Blair IA, Clapper M, Lazarus P, Li M, Muscat JE, Penning TM, Vachani A, Whitehead AS. Development of a genotyping microarray for studying the role of gene-environment interactions in risk for lung cancer. Journal of biomolecular techniques : JBT, 24(4):198-217, 2013. PMC3792704.  Read the article

5.         Behrend SW. Update on … patient education and counseling. Oncology nursing forum, 41(1):103-4, 2014.  Read the article

6.         Campbell M. The Vessel of a Nurse’s Voice. The American journal of nursing, 114(1):37, 2014.  Read the article

7.         Chen KT, Kim PD, Jones KA, Devarajan K, Patel BB, Hoffman JP, Ehya H, Huang M, Watson JC, Tokar JL, Yeung AT. Potential prognostic biomarkers of pancreatic cancer. Pancreas, 43(1):22-7, 2014. PMC3859961.  Read the article

8.         Costa LJ, Zhang MJ, Zhong XB, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani BN, Waller EK, Schouten H, Lazarus H, Meehan K, Sharma M, Kamble R, Vij R, Kumar S, Nishihori T, Kindwall-Keller T, Saber W, Hari PN. Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma. Biology of Blood and Marrow Transplantation, 19(11):1615-24, 2013.  Read the article

9.         de Souza JA, Wong YN. Financial Distress in Cancer Patients. Journal of medicine and the person, 11(2):73-7, 2013. PMC3859450.  Read the article

10.        Doss M. Linear No-Threshold Model VS. Radiation Hormesis. Dose-response : a publication of International Hormesis Society, 11:480-97, 2013. PMC3834742.  Read the article

11.        Doss M. Linear No-Threshold Model May Not Be Appropriate for Estimating Cancer Risk from CT. Radiology, 270(1):307-8, 2014.  Read the article

12.        Doss M, Kolb HC, Walsh JC, Mocharla V, Fan H, Chaudhary A, Zhu ZH, Alpaugh RK, Lango MN, Yu JQ. Biodistribution and Radiation Dosimetry of F-18-CP-18, a Potential Apoptosis Imaging Agent, as Determined from PET/CT Scans in Healthy Volunteers. Journal of Nuclear Medicine, 54(12):2087-92, 2013.  Read the article

13.        Hu L, Filippakis H, Huang HM, Yen TJ, Gjoerup OV. Replication Stress and Mitotic Dysfunction in Cells Expressing Simian Virus 40 Large T Antigen. Journal of Virology, 87(24):13179-92, 2013.  Read the article

14.        Hughes L, Ruth K, Rebbeck TR, Giri VN. Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men. Prostate Cancer and Prostatic Diseases, 16(4):308-14, 2013.  Read the article

15.        Kerlin MP, Tokar JL. Acute gastrointestinal bleeding. Annals of internal medicine, 159(11):793-4, 2013. [Letter].  Read the article

16.        Kruglov AA, Grivennikov SI, Kuprash DV, Winsauer C, Prepens S, Seleznik GM, Eberl G, Littman DR, Heikenwalder M, Tumanov AV, Nedospasov SA. Nonredundant Function of Soluble LT alpha(3) Produced by Innate Lymphoid Cells in Intestinal Homeostasis. Science, 342(6163):1243-6, 2013.  Read the article

17.        Li P, Du F, Yuelling LW, Lin T, Muradimova RE, Tricarico R, Wang J, Enikolopov G, Bellacosa A, Wechsler-Reya RJ, Yang ZJ. A population of Nestin-expressing progenitors in the cerebellum exhibits increased tumorigenicity. Nature Neuroscience, 16(12):1737-44, 2013.  Read the article

18.        Lloyd JC, Madden-Fuentes RJ, Nelson CP, Kokorowski PJ, Wiener JS, Ross SS, Kutikov A, Routh JC. The Publication Ranking Score for pediatric urology: Quantifying thought leadership within the subspecialty. Journal of Pediatric Urology, 9(6):1108-13, 2013.  Read the article

19.        Mehra R, Zhu F, Yang DH, Cai KQ, Weaver J, Singh MK, Nikonova AS, Golemis EA, Flieder DB, Cooper HS, Lango M, Ridge JA, Burtness B. Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers. Clinical Cancer Research, 19(23):6633-43, 2013.  Read the article

20.        Mehrazin R, Wong YN, Wu H, Al-Saleem T, Smaldone M. Renal Cell Carcinoma Metastasis to a Contralateral Oncocytoma in a Patient Presenting With Bilateral Synchronous Renal Tumors. Clinical genitourinary cancer, 11(4):E27-E9, 2013.  Read the article

21.        Miller SM, Hui SK, Wen KY, Scarpato J, Zhu F, Buzaglo J, Hernandez EE. Tailored telephone counseling to improve adherence to follow-up regimens after an abnormal pap smear among minority, underserved women. Patient education and counseling, 93(3):488-95, 2013. PMC3852173.  Read the article

22.        Monk BJ, Pujade-Lauraine E, Burger RA. Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease. Annals of Oncology, 24:53-8, 2013.  Read the article

23.        Natori A, Hayashi N, Soejima K, Deshpande GA, Takahashi O, Cristofanilli M, Ueno NT, Yamauchi H. A Comparison of Epidemiology, Biology, and Prognosis of Inflammatory Breast Cancer in Japanese and US Populations. Clinical breast cancer, 13(6):460-4, 2013.  Read the article

24.        O’Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT, Gotlib J, Jagasia M, Kropf P, Moore JO, Pallera A, Pinilla-Ibarz J, Reddy VV, Shah NP, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H. Chronic Myelogenous Leukemia, Version 1.2014 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network, 11(11):1327-40, 2013.  Read the article

25.        Papavasiliou P, Hoffman JP, Cohen SJ, Meyer JE, Watson JC, Chun YS. Impact of preoperative therapy on patterns of recurrence in pancreatic cancer. Hpb, 16(1):34-9, 2014.  Read the article

26.        Patel RR, Li T, Ross EA, Sesa L, Sigurdson ER, Bleicher RJ. The Effect of Simultaneous Peripheral Excision in Breast Conservation upon Margin Status. Indian journal of surgical oncology, 3(4):292-8, 2012. PMC3521544.  Read the article

27.        Press OW, Unger JM, Rimsza LM, Friedberg JW, LeBlanc M, Czuczman MS, Kaminski M, Braziel RM, Spier C, Gopal AK, Maloney DG, Cheson BD, Dakhil SR, Miller TP, Fisher RI. A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP-Rituximab versus CHOP+(131)Iodine-Tositumomab. Clinical Cancer Research, 19(23):6624-32, 2013.  Read the article

28.        Radu M, Semenova G, Kosoff R, Chernoff J. PAK signalling during the development and progression of cancer. Nature reviews Cancer, 14(1):13-25, 2013.  Read the article

29.        Smith ER, Yang WL, Yeasky T, Smedberg J, Cai KQ, Xu XX. Cyclooxygenase-1 Inhibition Prolongs Postnatal Ovarian Follicle Lifespan in Mice. Biology of Reproduction, 89(4):103, 1-8, 2013.  Read the article

30.        Sterious S, Simhan J, Uzzo RG, Gershman B, Li T, Devarajan K, Canter D, Walton J, Fogg R, Ginzburg S, Corcoran A, Smaldone MC, Kutikov A. Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members. The Journal of urology, 190(3):992-8, 2013.  Read the article

31.        Thomas C, Tulin AV. Poly-ADP-ribose polymerase: Machinery for nuclear processes. Molecular Aspects of Medicine, 34(6):1124-37, 2013.  Read the article

32.        Wang L, Chen X, Lin MH, Xue J, Lin T, Fan J, Jin L, Ma CM. Evaluation of the cone beam CT for internal target volume localization in lung stereotactic radiotherapy in comparison with 4D MIP images. Medical physics, 40(11):111709, 1-8, 2013.  Read the article

33.        Wong GS, Lee JS, Park YY, Klein-Szanto AJ, Waldron TJ, Cukierman E, Herlyn M, Gimotty P, Nakagawa H, Rustgi AK. Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment. Oncogenesis, 2:e59, 2013. PMC3759121.  Read the article

34.        Zaorsky NG, Sun YG, Wang ZX, Palmer J, Fortina PM, Solomides C, Werner-Wasik M, Dicker AP, Axelrod R, Campling B, Evans N, Cowan S, Lu B. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab. Cancer biology & therapy, 14(10):883-7, 2013.  Read the article

Posted in Uncategorized | Leave a comment